Araris Biotech AG

https://www.ararisbiotech.com

Araris Biotech AG is a spin-off company from the Paul Scherrer Institute (PSI) and ETH Zurich focusing on the commercialization of a novel antibody-drug conjugate (ADC)-linker technology. Araris' innovative platform allows for the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering. The resulting ADCs have a well-defined drug-to-antibody ratio, are stable and monomeric. All these favorable properties contribute to the high efficacy and low level of toxicity observed so far. In summary, the straightforward drug conjugation, versatility of the technology and high in vivo efficacy enable the generation of ADC compounds for the treatment of patients with a high unmet medical need. *

	Start	2019-02-01 established (s-off)
	Predecessor	Paul Scherrer Institute (PSI)
	Industry	antibody-drug conjugates (ADC) technology
	Person	Spycher, Philipp (Araris Biotech 201902– CEO + Co-Founder)
	Person 2	Grabulovski, Dragan (Covagen 200701– CSO + co-founder)

	Region	Zürich ZH
	Country	Switzerland
	Street	7 Otto-Stern-Weg c/o ETH Zürich
	City	8093 Zürich
		Address record changed: 2020-12-02

Basic data	Employees	A: 1 to 10 (2020-07-01)

		* Document for ï¿½About Sectionï¿½: Araris Biotech AG. (8/20/19). "Press Release: Araris Biotech AG Closes Seed Financing Round of CHF 2.5 Million". Zurich.

		Record changed: 2020-10-22

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Araris Biotech AG

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)